Workflow
Beingmate(002570)
icon
Search documents
贝因美(002570) - 2022年5月19日投资者关系活动记录表
2022-11-19 02:34
Financial Performance - In 2021, the company achieved a revenue of CNY 2.54 billion, with a net profit of CNY 73.31 million, representing a growth of 122.61% compared to 2020 [2] - In Q1 2022, the company reported a revenue of CNY 814 million, a year-on-year increase of 43.68%, and a net profit of CNY 20.13 million, also showing growth [2] Product Development and Sales - The company has successfully launched the main product "Aijia" and the new product "Keruixin," which have shown strong sales performance since 2022 [3] - The "Keruixin" product has gained consumer recognition due to its excellent formula and high cost-performance ratio, leading to a high repurchase rate [3] Market Strategy and Adaptation - The company has adapted to the challenges posed by the pandemic by ensuring the supply of raw materials and maintaining production operations, thus safeguarding its performance [4] - The shift towards new retail channels has been effective, with the new retail model showing strong sales growth, particularly for the "Keruixin" product, which nearly matched the total sales of 2021 in April 2022 [4] Industry Outlook - The infant formula industry is expected to experience increased competition, with smaller brands likely to exit the market, leading to higher industry concentration [4] - The company anticipates structural growth opportunities due to supportive policies for childbirth and an expected rebound in newborn population numbers [5] Management and Operational Improvements - Following the return of the founder as General Manager, the company has implemented significant reforms aimed at improving profitability and operational performance [5] - Key strategies include optimizing organizational structure, enhancing cost control measures, and transitioning towards a new retail model to improve overall operational efficiency [5]
贝因美(002570) - 2022 Q3 - 季度财报
2022-10-28 16:00
Financial Performance - The company's revenue for Q3 2022 was ¥802,854,226.97, representing a 49.62% increase compared to the same period last year[4] - The net profit attributable to shareholders decreased by 74.46% to ¥1,334,719.69, while the net profit excluding non-recurring items was -¥8,578,550.15, a 65.77% increase[4] - Sales revenue increased by 45.78% year-on-year, with a total increase of ¥759,146,200[10] - Net profit for the third quarter of 2022 was ¥47,172,900.31, representing an increase of 8.5% from ¥43,336,196.24 in the same period last year[27] - The net profit attributable to the parent company shareholders for Q3 2022 was ¥44,249,710.35, an increase from ¥38,749,901.96 in the same period last year, representing a growth of approximately 3.86%[28] - The total comprehensive income for Q3 2022 was ¥46,634,781.79, compared to ¥51,229,088.00 in Q3 2021, indicating a decrease of about 8.93%[28] Cash Flow and Liquidity - Operating cash flow for the year-to-date increased by 231.36% to ¥304,272,487.38[4] - Cash inflow from operating activities increased by 50.47% to ¥255,000,000, reflecting improved cash collection[12] - The operating cash flow for the period was ¥304,272,487.38, significantly higher than ¥91,825,044.89 in the previous year, marking an increase of approximately 231.36%[30] - Cash and cash equivalents at the end of Q3 2022 stood at ¥551,080,662.03, down from ¥640,302,877.54 at the beginning of the period, reflecting a decrease of about 13.88%[31] - The total cash inflow from operating activities was ¥2,547,418,295.48, compared to ¥1,692,950,522.51 in the previous year, showing an increase of approximately 50.53%[30] - The total cash outflow from operating activities was ¥2,243,145,808.10, up from ¥1,601,125,477.62, which is an increase of about 40.19%[30] - The net cash flow from investing activities was -¥89,291,451.91, a decrease from ¥239,712,088.55 in the same period last year, indicating a decline of approximately 137.24%[30] - The net cash flow from financing activities was -¥304,393,141.30, compared to -¥304,160,475.13 in the previous year, showing a slight increase in outflow[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,867,581,511.42, a decrease of 4.96% from the previous year[4] - The company's total assets as of September 30, 2022, amounted to ¥3,867,581,511.42, a decrease from ¥4,069,421,166.85 at the beginning of the year[24] - Current liabilities totaled ¥1,964,279,101.59, down 7.3% from ¥2,118,700,258.86 at the start of the year[24] - The company reported a decrease in total liabilities to ¥2,033,000,441.55 from ¥2,232,686,402.91 at the beginning of the year, a reduction of 8.9%[24] - The company's cash and cash equivalents decreased to ¥623,984,340.39 from ¥676,870,643.54 at the beginning of the year, reflecting a decline of 7.8%[24] - Inventory levels decreased to ¥365,008,925.70, down 28.0% from ¥505,645,822.70 at the beginning of the year[24] - Long-term equity investments increased to ¥125,798,201.76, up 7.3% from ¥117,505,055.87 at the beginning of the year[24] - The company's retained earnings showed an improvement, with a loss of ¥895,963,065.57 compared to a loss of ¥940,212,775.92 at the beginning of the year[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 67,614, with the largest shareholder, Beiyinmei Group Co., Ltd., holding 18.65% of shares[17] - Beiyinmei Group Co., Ltd. pledged 194.85 million shares and froze 44,200 shares, indicating significant financial maneuvers[17] - The company has repurchased a total of 15.76 million shares, accounting for 1.46% of the total share capital, which reflects a strategy to enhance shareholder value[18] Strategic Initiatives - The company is focused on expanding its market presence and enhancing its product offerings through strategic investments and partnerships[19] - The company is supporting the establishment of an industrial incubation fund by its wholly-owned subsidiary to strengthen the integration of industry and finance, aiming for future project acquisitions that align with its strategic development[19] - The company reported a significant decrease in investment income by 61.29%, amounting to a reduction of ¥11,634,800, due to the previous year's gains from the sale of a subsidiary[10] - The company transferred its wholly-owned subsidiary Guangxi Quanan Sheng Enterprise Management Co., Ltd. to a 48% stake, which is no longer included in the consolidated financial statements[20] - The company will calculate financial assistance interest at an annualized rate of 5% based on the actual amount and duration of funds used by Guangxi Quanan Sheng[20] Operational Efficiency - Operating costs rose by 99.66%, amounting to an increase of ¥782,229,600, primarily due to higher sales revenue[10] - Research and development expenses decreased by 39.20% to ¥1,484,000, indicating reduced investment in R&D[10] - The report indicates a need for improved cash flow management to counterbalance the significant decreases in cash flow from investment and financing activities[15] - The company is committed to timely disclosures regarding the progress of the industrial incubation fund and its associated projects[19] - Basic and diluted earnings per share remained stable at ¥0.04 for both Q3 2022 and Q3 2021[28] - The company reported a decrease in other comprehensive income, with a net amount of -¥538,118.52 for Q3 2022, compared to ¥7,892,891.76 in the same period last year[28]
贝因美(002570) - 2022 Q2 - 季度财报
2022-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥1.61 billion, representing a 43.95% increase compared to ¥1.12 billion in the same period last year[23]. - The net profit attributable to shareholders of the listed company was approximately ¥42.91 million, an increase of 28.01% from ¥33.52 million in the previous year[23]. - The net profit after deducting non-recurring gains and losses was approximately ¥27.36 million, reflecting a significant increase of 60.08% compared to ¥17.09 million in the same period last year[23]. - The net cash flow from operating activities reached approximately ¥186.10 million, a substantial increase of 412.18% from ¥36.34 million in the previous year[23]. - Basic earnings per share increased to ¥0.04, up 33.33% from ¥0.03 in the same period last year[23]. - Total revenue for the reporting period reached ¥1,614,360,138.82, representing a year-on-year increase of 43.95% compared to ¥1,121,481,666.83 in the same period last year[57]. - The company reported a net profit of ¥43,843,803.37 for the first half of 2022, compared to ¥38,065,464.65 in the same period of 2021, marking an increase of 15.5%[168]. - The total comprehensive income for the first half of 2022 was ¥43,719,463.40, compared to ¥40,962,410.80 in the previous year, an increase of 4.3%[168]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥4.08 billion, a slight increase of 0.26% from ¥4.07 billion at the end of the previous year[23]. - The net assets attributable to shareholders of the listed company were approximately ¥1.83 billion, reflecting a 2.43% increase from ¥1.79 billion at the end of the previous year[23]. - Total liabilities decreased slightly to ¥2,208,656,753.35 from ¥2,232,686,402.91, a decrease of approximately 1.1%[160]. - Total current assets increased to ¥2,206,368,524.58 as of June 30, 2022, from ¥2,183,321,715.52 at the beginning of the year, reflecting a growth of approximately 1.2%[158]. - The total equity of the company increased to ¥2,116,247,124.94 from ¥2,092,842,220.38, showing a growth of 1.1%[167]. Revenue Segments - Revenue from the milk powder segment was ¥1,190,471,160.39, accounting for 73.74% of total revenue, with a year-on-year growth of 18.20%[58]. - The sales revenue of children's powder increased by 286% year-on-year, while the sales of special medical formula milk powder grew by over 62.40%[36]. - E-commerce revenue amounted to ¥204,418,972.81, with a year-on-year increase of 12.48% in sales volume[43]. - The sales volume of milk powder increased by 30.64% to 10,396.19 tons, while production volume rose by 31.17% to 10,921.96 tons[45]. Investments and R&D - The total investment amount during the reporting period was ¥99,316,390.81, representing a significant increase of 226.84% compared to ¥30,386,666.80 in the same period last year[72]. - The company has 21 invention patents and 60 registered formula products for infant formula milk powder, showcasing its strong R&D capabilities[47]. - Research and development expenses decreased by 28.95% to ¥10,698,461.48 from ¥15,058,142.75[54]. - The company is focusing on expanding its ODM and OEM business to optimize its industrial structure and improve capacity utilization[36]. Market Strategy and Operations - The company has strengthened its marketing strategy and operational efficiency under the leadership of its founder, laying a solid foundation for future growth[36]. - The online and offline integration of the new retail business model is being emphasized, with sales through e-commerce platforms like JD and Tmall[39]. - The company plans to continue expanding its product offerings and market presence, focusing on innovation in new product development and technology[62]. Risks and Challenges - The company has highlighted potential risks and countermeasures in its future development outlook[5]. - The company continues to explore precise nutrition formula products and other related services to mitigate risks from declining newborn population[86]. - The company is actively managing supply chain risks and inventory control to mitigate related risks and develop effective alternatives[87]. - The company is closely monitoring the impact of the pandemic and is committed to employee health and safety while leveraging its R&D and production capabilities to support pandemic prevention efforts[87]. Shareholder Information - The total number of shares increased to 1,080,043,333, with 57,517,858 shares being newly issued, representing 5.33% of the total before the change[137]. - The company’s major shareholder, Beiyinmei Group, reduced its holdings by 10.8 million shares, now holding 201,418,500 shares, which is 18.65% of the total[138]. - The largest shareholder, Beining Group Co., Ltd., holds 19.65% of the shares, totaling 212,218,500 shares, with 194,894,200 shares pledged[145]. - The company has repurchased a total of 8,286,307 shares, accounting for 0.77% of the total share capital[145]. Legal and Compliance - The total amount involved in economic disputes where the company is the plaintiff is CNY 26.46 million, with no expected liabilities[108]. - The total amount involved in economic disputes where the company is the defendant is CNY 38.45 million, currently under court review[108]. - The company has frozen 4,466,576 shares held by its controlling shareholder, accounting for 0.41% of the total share capital, due to a court ruling[109].
贝因美(002570) - 2022 Q1 - 季度财报
2022-04-29 16:00
Financial Performance - The company's revenue for Q1 2022 was ¥814,448,112.17, representing a 43.68% increase compared to ¥566,858,555.71 in the same period last year[4] - Net profit attributable to shareholders was ¥20,126,374.67, up 38.45% from ¥14,537,381.04 year-on-year[4] - The net profit excluding non-recurring gains and losses surged by 266.35% to ¥15,517,744.73 from ¥4,235,790.79 in the previous year[4] - Basic earnings per share doubled to ¥0.02 from ¥0.01 year-on-year[4] - Net profit for Q1 2022 reached ¥20,984,457.67, representing a 11.6% increase from ¥18,810,095.29 in Q1 2021[24] - The net profit attributable to the parent company was ¥20,126,374.67, compared to ¥14,537,381.04 in the same period last year, marking a growth of 38.5%[24] - Basic and diluted earnings per share for Q1 2022 were both ¥0.02, up from ¥0.01 in Q1 2021[24] Cash Flow and Liquidity - Operating cash flow increased by 145.02% to ¥52,895,828.43, compared to ¥21,588,202.87 in the same quarter last year[4] - The net cash flow from operating activities increased by ¥31,307.6 million, reflecting a growth of 145.02% year-on-year[11] - The net cash flow from operating activities for the current period is ¥52,895,828.43, an increase of 144.5% compared to ¥21,588,202.87 in the previous period[26] - Total cash inflow from operating activities reached ¥843,266,621.84, up from ¥631,773,462.88, reflecting a growth of 33.4%[26] - Cash outflow from operating activities was ¥790,370,793.41, compared to ¥610,185,260.01 in the previous period, indicating an increase of 29.5%[26] - The ending balance of cash and cash equivalents is ¥606,082,937.03, down from ¥640,302,877.54, a decrease of 5.4%[27] - The company received ¥250,000,000.00 in borrowings, a decrease from ¥300,000,000.00 in the previous period[27] - Cash received from other financing activities was ¥206,813,283.34, compared to ¥332,522,663.54 previously, reflecting a decline of 37.7%[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,112,136,081.48, a 1.05% increase from ¥4,069,421,166.85 at the end of the previous year[4] - The company's equity attributable to shareholders rose by 0.93% to ¥1,802,455,204.51 from ¥1,785,836,479.80 at the end of the last year[4] - Total liabilities as of the end of Q1 2022 were ¥2,257,924,509.83, slightly up from ¥2,232,686,402.91 at the end of Q1 2021[20] - Short-term borrowings rose to CNY 1,111,156,125.70 from CNY 1,011,350,119.07, indicating an increase of approximately 9.9%[19] Investments and Joint Ventures - The company established a joint venture, Yibei Intelligent (Hangzhou) Nutrition Technology Co., Ltd., with a registered capital of CNY 10 million, where the company holds a 40% stake[16] - The company’s long-term equity investments increased from CNY 117,505,055.87 to CNY 122,295,456.64, reflecting a growth of approximately 4.7%[19] Inventory and Receivables - The company reported a significant increase in accounts receivable, which decreased by 48.51%, while prepayments surged by 152.41%[8] - The accounts receivable decreased slightly from CNY 741,811,792.81 to CNY 738,009,158.53, a marginal decline of about 0.4%[18] - Inventory decreased significantly from CNY 505,645,822.70 to CNY 395,590,039.67, a reduction of about 21.8%[19] Operating Costs and Expenses - Total operating costs for Q1 2022 were ¥773,542,287.77, up 42.4% from ¥543,555,353.94 in Q1 2021[23] - Research and development expenses for Q1 2022 were ¥4,553,454.36, a slight decrease from ¥4,754,671.25 in Q1 2021[23] Comprehensive Income - The company reported a total comprehensive income of ¥17,142,007.71 for Q1 2022, compared to ¥17,413,766.62 in Q1 2021[24]
贝因美(002570) - 2021 Q4 - 年度财报
2022-04-29 16:00
Financial Performance - The company's operating revenue for 2021 was ¥2,539,560,089.66, a decrease of 4.71% compared to ¥2,665,134,436.24 in 2020[22] - The net profit attributable to shareholders in 2021 was ¥73,314,574.33, a significant increase of 122.61% from a loss of ¥324,279,930.45 in 2020[22] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,296,140.06, up 101.52% from a loss of ¥481,509,592.22 in the previous year[22] - The net cash flow from operating activities reached ¥246,743,802.53, representing a remarkable increase of 713.34% compared to ¥30,336,940.67 in 2020[22] - Basic earnings per share for 2021 were ¥0.07, a turnaround from a loss of ¥0.32 per share in 2020, marking a 121.88% improvement[22] - The total assets at the end of 2021 were ¥4,069,421,166.85, reflecting a slight increase of 0.87% from ¥4,034,293,142.99 at the end of 2020[22] - The weighted average return on equity was 4.78%, a significant recovery from -20.92% in 2020, indicating a 25.70% improvement[22] - The net assets attributable to shareholders of the listed company increased by 22.89% to CNY 1,785,836,479.80 from CNY 1,453,144,556.61[23] - The total operating revenue for the fourth quarter was CNY 881,491,923.14, with a total annual revenue of CNY 2,539,559,189.66[26] - The net profit attributable to shareholders for the fourth quarter was CNY 34,564,672.37, contributing to an annual net profit of CNY 73,318,574.35[26] - The cash flow from operating activities in the fourth quarter was CNY 154,918,757.64, showing a significant increase compared to previous quarters[26] Business Strategy and Market Position - The company is positioned among the top 20 enterprises in China's dairy industry, focusing on high-quality infant nutrition products[34] - The company has completed a full industry chain layout, including R&D, production, and sales, enhancing its competitive edge in the market[34] - The company is transitioning towards a new retail business model, achieving preliminary results in this strategic shift[34] - The overall consumption scale of dairy products and milk-based nutritional products continues to grow, driven by increasing health awareness among consumers[34] - The company launched several new products in 2021, including "可睿欣" infant formula and "睛彩" series nutritional products, expanding its product matrix[41] - The company’s sales through e-commerce channels reached 392.48 million yuan, representing a year-on-year increase of 6.83%[46] - The company’s flagship product "爱加" was recognized as the most popular infant formula by parenting websites in 2021, enhancing brand reputation[40] - The company is focused on developing personalized nutrition products for families, including a series of children's formula milk powders and health products[70] - The company aims to enhance brand recognition and authority through targeted marketing strategies, including collaborations with CCTV to reach consumers in lower-tier markets[99] - The focus remains on strengthening core product categories and expanding into niche markets, particularly in high-growth segments like goat milk powder and organic products[100] Research and Development - The company holds 21 invention patents and has registered 60 infant formula products, showcasing its strong R&D capabilities in the infant food sector[51] - R&D expenses increased by 113.12% year-on-year, amounting to ¥26,135,300.31, primarily due to increased investment in formula registration research[70] - The number of R&D personnel rose to 29, an increase of 11.54% from 26 in the previous year, with a notable increase in bachelor's degree holders by 85.71%[71] - The proportion of R&D investment to operating revenue increased to 1.03% from 0.46%, reflecting a significant rise of 0.57%[71] - Research and development investments increased by 30%, focusing on innovative baby nutrition products[132] Corporate Governance - The company held 7 shareholder meetings during the reporting period, ensuring equal treatment of all shareholders and facilitating their rights[108] - The board of directors convened 18 times, with 8 members including 3 independent directors, complying with legal and regulatory requirements[110] - The supervisory board met 9 times, consisting of 3 members, including 1 employee representative, fulfilling its supervisory functions over the company's financial status[111] - The company established a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards[114] - The company maintains complete independence from its controlling shareholder in terms of business, personnel, assets, organization, and finance[117] - The company has a complete and independent financial management system, ensuring the independence of its financial operations[117] - The company has implemented a system for insider information registration, adhering to relevant regulations during the preparation of periodic reports[115] - The company continuously improves its governance structure in accordance with laws and regulations, enhancing transparency and protecting investor rights[107] Social Responsibility and Environmental Commitment - The company has established a comprehensive environmental management system, ensuring that pollutant emissions are within the prescribed limits and has not faced any environmental accidents during the reporting period[173] - The company donated 2,000 boxes of formula milk worth over 1.87 million yuan to improve local children's nutrition in Guizhou Province and provided over 1.5 million yuan worth of formula milk to flood victims in Henan Province during the reporting period[174] - The company has been actively involved in three major social welfare projects: "Love Baby," "育婴" (Child Rearing), and "亲母" (Mother Care), focusing on providing support and knowledge for the healthy growth of children[175] - The company emphasizes the importance of scientific and safe products and services in the baby and child industry, viewing this as a core social responsibility[176] Legal and Compliance Issues - The company faced disciplinary actions from the Shenzhen Stock Exchange for failing to correct significant discrepancies in its earnings reports in a timely manner[135] - The chairman and general manager, Xie Hong, along with the former financial director, Chen Bin, received a warning from the China Securities Regulatory Commission for inaccurate disclosures[133] - The company has been under scrutiny for its information disclosure practices, leading to penalties and warnings from regulatory bodies[133] - The company reported a significant discrepancy in its 2020 earnings forecast, initially predicting a net profit of between 54 million to 80 million CNY, but later revising it to a net loss of 327.68 million CNY[134] Employee Management and Performance - The total number of employees at the end of the reporting period was 1,933, with 846 in the parent company and 1,087 in major subsidiaries[154] - The company has a comprehensive training system for employees, focusing on various areas including new employee orientation and professional skills enhancement[157] - The company has established a performance bonus system linked to both individual and company performance to enhance employee satisfaction and loyalty[156] - The management team has a performance evaluation mechanism that emphasizes operational goals and includes both annual and monthly assessments[161] Related Party Transactions - The company reported a total of 8,125.3 million yuan in related party transactions for 2021, with a fair pricing principle applied[196] - The procurement of raw materials accounted for 6.22% of the total related party transactions, amounting to 22,500 million yuan[196] - The company engaged in a related party transaction with its parent company for the purchase of promotional products, totaling 1,962.3 million yuan, representing 1.50% of the same type of transactions[196] - The company’s related party transactions for labor services amounted to 60.85 million yuan, representing 0.57% of the total[197] Investment and Subsidiary Activities - The company signed a new subsidiary, Yichang Xiaoshuidi New Retail Co., Ltd., with an investment of ¥2,750,000.00, acquiring a 55% stake[65] - The company established a new subsidiary, Yichang Little Water Drop New Retail Co., Ltd., with an investment of CNY 2,750,000 and a 55% ownership stake on November 26, 2021[188] - The company transferred 52% equity of Guangxi Quanan Sheng Enterprise Management Co., Ltd. on September 28, 2021, resulting in a decrease of one consolidated entity[188] Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue growth of 25%[132] - New product launches are expected to contribute an additional 300 million RMB in revenue over the next year[132] - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[132]
贝因美(002570) - 2021 Q3 - 季度财报
2021-10-29 16:00
Financial Performance - The company's revenue for Q3 2021 was ¥536,586,499.69, a decrease of 25.26% compared to the same period last year[4] - The net profit attributable to shareholders was ¥5,225,243.65, down 33.87% year-on-year[4] - Total operating revenue for the third quarter was ¥1,658,068,166.52, a decrease of 24.8% compared to ¥2,205,094,125.28 in the same period last year[26] - Net profit for the quarter was ¥43,336,196.24, a decline of 25.6% from ¥58,255,965.85 in the previous year[27] - The company's basic earnings per share remained at ¥0.01, unchanged from the previous year[4] - The company reported a basic earnings per share of ¥0.04, compared to ¥0.05 in the same quarter last year[28] Cash Flow - The net cash flow from operating activities increased by 294.54% to ¥91,825,044.89 year-to-date[4] - The net cash flow from operating activities for Q3 2021 was ¥91,825,044.89, a significant increase compared to ¥23,273,909.74 in Q3 2020, reflecting improved operational efficiency[31] - The net cash flow from financing activities decreased by 1430.93% year-on-year, with an absolute decrease of 327.01 million RMB, primarily due to an increase in the payment of bill guarantees[14] - The net increase in cash and cash equivalents decreased by 38.18% year-on-year, with an absolute decrease of 16.13 million RMB, mainly due to the reduction in net cash flow from financing activities[14] - The company reported a total cash inflow from financing activities of ¥1,337,026,441.31, compared to ¥1,534,252,307.97 in Q3 2020, indicating a decrease in financing activities[32] - Cash outflows for financing activities totaled ¥1,641,186,916.44, an increase from ¥1,511,399,012.07 in the previous year, leading to a net cash flow from financing activities of -¥304,160,475.13[32] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,140,693,087.45, reflecting a 2.64% increase from the end of the previous year[4] - The total assets increased to ¥4,140,693,087.45 from ¥4,034,293,142.99, reflecting a growth of 2.6%[24] - Total liabilities rose to ¥2,593,716,891.10, compared to ¥2,528,466,034.64, marking an increase of 2.6%[24] - The company's total non-current assets were reported at ¥1,936,707,198.58, slightly down from ¥1,954,764,618.14[24] Investments and Expenses - Research and development expenses rose by 126.05% to ¥2,442,000.00, driven by new national standards requirements[10] - Research and development expenses increased to ¥24,418,402.43, up from ¥10,802,290.38 year-on-year, indicating a focus on innovation[27] - The company’s investment income decreased by 62.49% to ¥1,900,000.00, primarily due to reduced gains from subsidiary equity transfers and fund investments[10] - The cash inflow from investment activities included ¥270,673,073.75 from other investment-related activities, a significant increase from ¥86,723,775.50 in Q3 2020[32] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 97,775[16] - The largest shareholder, Beiyinmei Group Co., Ltd., holds 20.75% of the shares, amounting to 212,218,500 shares, with 194,850,000 shares pledged[16] Other Financial Metrics - Other comprehensive income after tax was ¥7,892,891.76, compared to ¥1,511,491.30 in the previous year, showing significant improvement[28] - The company received tax refunds amounting to ¥13,448,373.34, compared to ¥2,423,048.33 in the previous year, indicating improved tax recovery[31] - Cash received from sales of goods and services was ¥1,540,589,297.43, down from ¥1,985,211,666.07 in the previous period[30] - Cash received from other operating activities was ¥138,912,851.74, a decrease from ¥342,750,746.61 in Q3 2020, reflecting changes in operational cash flows[31] - The company paid ¥257,753,096.63 in employee compensation, slightly down from ¥268,039,362.55 in the same quarter last year[31] Business Developments - The company plans to invest 60 million RMB in the maternal and child health service business through its subsidiary, Mamibebe[20] - The company has completed the registration change for its investment in Mamibebe, holding 48.46% of the registered capital[20] - The company has not completed the acquisition of 100% equity in Zhejiang Pucheng Investment Co., Ltd. as of the report date[19] Inventory and Receivables - Accounts receivable increased to 743,574,130.80 RMB from 642,802,698.32 RMB year-on-year[22] - Inventory as of September 30, 2021, was 541,355,513.46 RMB, slightly up from 528,260,644.48 RMB at the end of 2020[22]
贝因美(002570) - 2021 Q2 - 季度财报
2021-07-30 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥1,121,481,666.83, a decrease of 24.59% compared to ¥1,487,119,634.38 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥33,524,658.31, down 21.85% from ¥42,896,171.34 in the previous year[21]. - The net profit after deducting non-recurring gains and losses increased by 430.32% to ¥17,088,924.55 from ¥3,222,399.77 in the same period last year[21]. - The net cash flow from operating activities was ¥36,335,620.30, representing an increase of 108.67% compared to ¥17,413,342.10 in the previous year[21]. - Total revenue for the reporting period was approximately CNY 1,043,376,415.49, representing a year-on-year decrease of 26.47%[33]. - The company reported a total revenue of approximately 1.48 billion yuan for the first half of 2021, reflecting a year-on-year increase of 8%[69]. - The net profit attributable to shareholders for the same period was approximately 249 million yuan, a decrease of 10% compared to the previous year[69]. - The company reported a net loss of CNY 980,002,691.94 as of June 30, 2021, compared to a net loss of CNY 1,013,527,350.25 at the end of 2020, showing an improvement of approximately 3.29%[140]. - The total comprehensive income for the first half of 2021 was CNY 40,962,410.80, down from CNY 50,001,194.71 in the same period last year[148]. - The company reported a significant increase in cash inflow from financing activities, totaling CNY 508,614,625.24, compared to CNY 1,106,612,983.80 in the previous year[159]. Assets and Liabilities - The total assets at the end of the reporting period were ¥4,145,393,402.28, an increase of 2.75% from ¥4,034,293,142.99 at the end of the previous year[21]. - The company's total liabilities increased, with short-term loans rising to ¥1,327,392,141.68, accounting for 32.02% of total assets[59]. - The total liabilities as of June 30, 2021, were CNY 2,608,683,883.13, up from CNY 2,528,466,034.64, indicating an increase of approximately 3.17%[140]. - The total equity attributable to shareholders increased to CNY 1,489,566,161.07 from CNY 1,453,144,556.61, a rise of about 2.50%[140]. - The total current assets as of June 30, 2021, amounted to CNY 2,217,163,337.95, an increase from CNY 2,079,528,524.85 as of December 31, 2020, representing a growth of approximately 6.65%[137]. Earnings and Shareholder Information - The basic earnings per share decreased by 25.00% to ¥0.03 from ¥0.04 in the same period last year[21]. - The diluted earnings per share also decreased by 25.00% to ¥0.03 from ¥0.04 in the previous year[21]. - The total number of shares after the recent changes is 1,022,520,000[116]. - The company repurchased 10,766,307 shares, representing 1.05% of the total share capital[124]. - The total number of ordinary shareholders at the end of the reporting period was 108,503[122]. Research and Development - Research and development expenses increased by 124.44% to ¥15,058,142.75, indicating a significant investment in new projects[51]. - The company holds 24 invention patents and has registered 60 infant formula products, showcasing its strong R&D capabilities[44]. - The company has focused on developing precision nutrition formula products and other related services to address the declining birth rate risk[71]. - The company has invested in research and development to enhance its product capabilities and support pandemic prevention efforts[71]. Market and Product Development - The company's main business involves the research, production, and sales of infant food, with key products including infant formula, nutritional rice flour, and other complementary foods[29]. - The company launched new products such as "可睿欣" infant formula and "冠军宝贝" rice flour, focusing on precise nutrition and digestive health[31]. - The company aims to enhance its brand recognition through programs like "妈妈英雄汇" and continues to innovate in product offerings[31]. - The company is focused on expanding its market presence through new retail models and partnerships, aiming to drive business growth[49]. Cash Flow and Financial Management - The net cash flow from investing activities decreased by 186.73% to -¥32,528,885.36, mainly due to a reduction in the net amount recovered from financial products[51]. - The net cash flow from financing activities also decreased by 186.60% to -¥35,746,629.69, attributed to a decline in cash received from bill discounts compared to the previous year[51]. - The cash inflow from operating activities indicates improved operational efficiency and profitability compared to the previous year[159]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[161]. Corporate Governance and Compliance - The company has no significant equity or non-equity investments during the reporting period[64][65]. - The company has no major litigation or arbitration matters during the reporting period[91]. - The half-year financial report has not been audited[88]. - The company has established a comprehensive environmental management system, with pollutant emissions within the prescribed limits, and has not experienced any environmental accidents[81]. Social Responsibility - The company donated 2,000 boxes of formula milk (valued at over 1.87 million yuan) to help improve the nutritional health of children in Danjiang County, Guizhou Province[82].
贝因美:关于举行2020年度网上业绩说明会暨参加浙江辖区上市公司投资者网上集体接待日活动的公告
2021-05-06 11:55
证券代码:002570 证券简称:贝因美 公告编号:2021-047 贝因美股份有限公司 关于举行 2020 年度网上业绩说明会暨参加浙江辖区 上市公司投资者网上集体接待日活动的公告 | --- | --- | |---------------------------------------------------|------------------------------------------------------------------------| | 假记载、误导性陈述或重大遗漏。 | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 | | 贝因美股份有限公司(以下简称"公司") | 2020 年年度报告已于 2021 年 4 | | 月 30 | 日披露,为进一步加强公司与投资者的沟通交流,让广大投资者能进一步 | | 了解公司 2020 | 年经营情况,使广大投资者能更深入全面的了解公司未来发展战 | | 略,公司将于 2021 年 5 月 13 | 日(星期四)在"全景·路演天下"网站( http://rs.p5w.net ) | | 举办 2020 | 年度业绩说明会。 ...
贝因美(002570) - 2020 Q4 - 年度财报
2021-04-29 16:00
Financial Performance - The company's operating revenue for 2020 was ¥2,665,134,436.24, a decrease of 4.32% compared to ¥2,785,476,110.41 in 2019[18]. - The net profit attributable to shareholders was -¥324,279,930.45, representing a decline of 214.58% from -¥103,082,284.52 in the previous year[18]. - The total assets at the end of 2020 were ¥4,034,293,142.99, down 7.81% from ¥4,375,965,959.55 at the end of 2019[18]. - The net assets attributable to shareholders decreased by 13.92% to ¥1,453,144,556.61 from ¥1,688,037,529.45 in 2019[18]. - The basic earnings per share for 2020 was -¥0.32, a decline of 220.00% compared to -¥0.10 in 2019[18]. - The weighted average return on net assets was -20.92%, a decrease of 15.02 percentage points from -5.90% in the previous year[18]. - The company's revenue after deducting non-operating income was ¥2,543,840,251.17, compared to ¥2,609,457,313.52 in 2019[19]. - The company reported uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years[18]. - The company reported a significant increase in fixed assets, which decreased to ¥1,031,245,462.24, now 25.56% of total assets, down from 32.90%, a decline of 7.34%[82]. - The company reported a significant decline in net profit, with losses reaching 69.6 million CNY in one of its subsidiaries[97]. Cash Flow and Investments - The net cash flow from operating activities improved to ¥30,336,940.67, a significant increase of 160.75% from -¥49,941,001.56 in 2019[18]. - The net cash flow from operating activities in Q2 2020 was approximately ¥14.06 million, showing an increase compared to Q1 2020[23]. - Investment cash inflow increased by 33.28% to ¥209,039,069.30, primarily due to proceeds from the disposal of subsidiary equity and recovered bank wealth management investments[78]. - Financing cash inflow rose by 31.20% to ¥2,201,597,240.61, mainly from the recovery of pledged deposits and discounted notes[78]. - The net increase in cash and cash equivalents was ¥52,166,904.63, a 114.49% increase compared to the previous year[78]. Product Development and Market Strategy - The company launched several new products in 2020, including the "Shulile" special medical purpose infant protein partially hydrolyzed formula and "Kidsclub" children's health snacks, expanding its product matrix[30]. - The company aims to enhance its operational efficiency and management structure, which is expected to lay a solid foundation for future performance growth[30]. - The infant formula market is projected to grow as demand shifts from first and second-tier cities to third and fourth-tier cities, indicating substantial potential for future expansion[30]. - The company is focusing on research and development of new nutritional products to enhance its market competitiveness[97]. - The company plans to expand its product offerings, including new infant nutrition products and beverages[98]. Operational Efficiency and Management - The company has implemented advanced management systems, including MES, WMS, and ERP, to enhance production efficiency[38]. - The company has optimized its organizational structure and implemented a flat management approach to improve operational efficiency[49]. - The company is focused on enhancing its logistics services to improve distribution efficiency and customer satisfaction[98]. - The company is committed to optimizing its distribution channels and enhancing new retail strategies to improve customer engagement and sales performance[103]. Research and Development - The company has established a complete industrial system, including a national-level infant food R&D center and a post-doctoral workstation[32]. - The company holds 23 invention patents and has registered 60 infant formula products, showcasing its strong R&D capabilities[37]. - The company is enhancing its research and development efforts by utilizing big data for precise nutrition design in infant formula[104]. - The company plans to invest in technology innovation, particularly in blockchain for food safety in maternal and infant nutrition products[104]. Shareholder and Corporate Governance - The company has not distributed cash dividends in recent years, focusing instead on stock repurchases as a means of returning value to shareholders[109]. - The company has engaged in related party transactions, including a procurement transaction with a total amount of 132,340 yuan, which was approved and settled through bank transfer[131]. - The company strictly adheres to corporate governance regulations, enhancing transparency and fairness in information disclosure[199]. - The company held its shareholder meetings in compliance with legal requirements, ensuring equal treatment of all shareholders[200]. Social Responsibility and Community Engagement - The company has actively participated in social responsibility initiatives, focusing on the health and development of infants and children since its establishment in 1992[148]. - The company has launched three major social welfare projects: "Love Baby Project," "育婴工程" (Child Rearing Project), and "亲母工程" (Mother Care Project) to support families and promote healthy growth[149]. Market Presence and Competition - The company has a significant presence in the overseas market, with investments in Ireland and Australia, totaling approximately 160.94 million yuan and 379.41 million yuan respectively[35][36]. - The company anticipates a shift in consumer preference towards domestic brands due to safety concerns regarding imported infant formula[101]. - The company aims to enhance brand recognition and authority through targeted marketing strategies, including collaborations with CCTV[102]. - The company is exploring potential acquisitions to strengthen its market position, with a budget of 300 million RMB allocated for this purpose[186].
贝因美(002570) - 2021 Q1 - 季度财报
2021-04-29 16:00
Financial Performance - The company's revenue for Q1 2021 was ¥566,858,555.71, a decrease of 20.59% compared to ¥713,805,176.65 in the same period last year[9] - Net profit attributable to shareholders was ¥14,537,381.04, representing an increase of 12.23% from ¥12,953,651.28 year-on-year[9] - The net profit after deducting non-recurring gains and losses surged by 297.92% to ¥4,235,790.79, compared to ¥1,064,471.91 in the previous year[9] - The company reported a net loss of CNY 998,989,969.21, slightly improved from a loss of CNY 1,013,527,350.25 in the previous period[36] - Net profit for the first quarter reached CNY 18,810,095.29, compared to CNY 15,575,643.94 in the same period last year, representing a growth of about 20.00%[43] - The profit attributable to shareholders of the parent company was CNY 14,537,381.04, up from CNY 12,953,651.28, indicating an increase of approximately 12.23%[43] - The company reported a total comprehensive income of CNY 17,790,643.60, down from CNY 30,216,294.82 in the previous year[44] Cash Flow - The net cash flow from operating activities increased significantly by 544.56% to ¥21,588,202.87, up from ¥3,349,282.25 in the same period last year[9] - The net cash flow from operating activities for the current period is CNY 21,588,202.87, compared to CNY 3,349,282.25 in the previous period, indicating a significant improvement[51] - Total cash inflow from operating activities is CNY 631,773,462.88, down from CNY 809,599,057.28 in the previous period, reflecting a decrease of approximately 22%[51] - Cash inflow from sales of goods and services is CNY 514,976,941.58, down from CNY 690,252,945.76, indicating a decline of approximately 26%[54] - The net cash flow from operating activities for the current period is CNY 236,819,266.31, a decrease from CNY 619,374,605.07 in the previous period, showing a decline of about 62%[54] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,141,897,181.00, reflecting a growth of 2.67% from ¥4,034,293,142.99 at the end of the previous year[9] - The net assets attributable to shareholders increased by 0.93% to ¥1,466,662,485.96, compared to ¥1,453,144,556.61 at the end of the previous year[9] - Total liabilities increased from CNY 2,528,466,034.64 to CNY 2,618,279,429.05, an increase of about 3.9%[35] - Current liabilities increased to CNY 2,453,840,982.88 from CNY 2,362,469,500.73, representing a growth of about 3.86%[35] - The company's total equity rose to CNY 1,523,617,751.95 from CNY 1,505,827,108.35, reflecting an increase of approximately 1.18%[36] Shareholder Information - The company had a total of 63,650 common shareholders at the end of the reporting period[13] - The largest shareholder, Beiyinmei Group Co., Ltd., held 20.75% of the shares, amounting to 212,218,500 shares, with 192,850,000 shares pledged[13] Expenses and Investments - Financial expenses decreased by 70.57% compared to the same period last year, a reduction of 38.65 million RMB, mainly due to a decrease in exchange losses[18] - Investment income decreased by 66.68% compared to the same period last year, a reduction of 5.57 million RMB, mainly due to lower returns from fund investments[18] - Research and development expenses rose to CNY 4,754,671.25, compared to CNY 2,639,629.91, marking an increase of about 80.00%[42] Other Financial Metrics - The weighted average return on net assets was 1.00%, up from 0.76% in the same period last year, indicating improved profitability[9] - The company experienced a credit impairment loss of CNY -6,674,903.01, a significant improvement from CNY 14,927,434.29 in the previous period[42] - The company's tax expenses decreased to CNY 1,112,795.20 from CNY 3,745,561.94, reflecting a reduction of approximately 70.32%[43] - The company reported a significant increase in tax refunds received, up 131.42% compared to the same period last year, an increase of 1.80 million RMB[18] Changes in Receivables and Payables - Accounts receivable financing decreased by 33.65% compared to the beginning of the period, a reduction of 12.5 million RMB, mainly due to a decrease in notes receivable[17] - Prepayments increased by 408.53% compared to the beginning of the period, an increase of 73.36 million RMB, primarily due to an increase in advance payments for goods[17] - Other receivables increased by 35.18% compared to the beginning of the period, an increase of 6.46 million RMB, mainly due to an increase in temporary payments receivable[17] Cash Flow from Investment Activities - Cash flow from investment activities decreased by 98.75% compared to the same period last year, a reduction of 83.40 million RMB, mainly due to a decrease in bank wealth management investments recovered[19] - The cash flow from investing activities shows a net outflow of CNY 35,130,372.28, a decrease from a net inflow of CNY 62,604,648.40 in the previous period[51] Future Plans - The company plans to participate in the establishment of a new insurance company with a registered capital of 1.5 billion RMB, contributing 225 million RMB[21]